Published • loading... • Updated
Ashley Graham Calls Weight Loss Drugs a 'Smack in the Face' to Body Positivity Movement
Ashley Graham says the weight-loss drug trend undercuts body positivity, while she says plus-size women will still be visible.
- Model Ashley Graham, 38, criticized the GLP-1 trend in a Marie Claire interview, calling the popularity of weight-loss drugs "a smack in the face" to the body positivity movement.
- Describing the renewed focus on thinness as "really disheartening," Graham noted a cultural pendulum swinging away from the inclusivity that defined recent years.
- Asserting that inclusivity remains essential, Graham stated that plus-size women will continue to exist, adding, "This drug isn't going to wipe out a whole statistic of women."
- Younger influencers raised on social media offer a counter-narrative, with Graham praising their platform to tell the next generation, "Be yourself, be who you want to be."
- As GLP-1 receptor agonists become increasingly popular in celebrity circles, Graham emphasizes that confidence should not be limited by body size, regardless of shifting beauty standards.
Insights by Ground AI
17 Articles
17 Articles
The hype for weight loss shots is growing - but Ashley Graham is sounding the alarm. The Pluz Size model sees this as a step backwards for body acceptance and finds clear words. However, giving up is not an option for them.
Plus-Size Supermodel Rages That Weight-Loss Shots Are a Death Blow to 'Body Positivity' Movement She Helped Create, 'Feels Like a Smack in the Face!'
Plus-size supermodel and one of the leading voices in the "body positivity" sphere, Ashley Graham, is raging about the exploding popularity of GLP-1 weight-loss drugs like Ozempic and Wegovy.
·United States
Read Full Article
In an interview with the American version of "Marie Claire", the model deplores the growing popularity of anti-obesity injections among young women.
·Paris, France
Read Full Article
Coverage Details
Total News Sources17
Leaning Left5Leaning Right6Center0Last UpdatedBias Distribution55% Right
Bias Distribution
- 55% of the sources lean Right
55% Right
L 45%
R 55%
Factuality
To view factuality data please Upgrade to Premium
